Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) (KONQUER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04771897
Recruitment Status : Recruiting
First Posted : February 25, 2021
Last Update Posted : June 21, 2022
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
Bexion Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2022
Estimated Study Completion Date : October 2023